Skip to content

Psychological Support Based on Positive Suggestions (PSBPS) on Mental Health Morbidity and Cognitive Function

Randomized Controlled Trial to Evaluate Efficacy of Psychological Support Based on Positive Suggestions (PSBPS) on Mental Health Morbidity and Cognitive Function

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04045210
Enrollment
274
Registered
2019-08-05
Start date
2019-08-30
Completion date
2025-03-15
Last updated
2026-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness

Brief summary

The Researchers are trying to evaluate efficacy of a psychotherapeutic approach that can be applied to those who are critically ill. The daily approach in the Intensive Care Unit (ICU) is designed to provide patients with psychological support, reassurance, and explanations of where they are and what is happening to them.

Detailed description

Background: Psychological morbidity is a major health problem among survivors of critical illness, with no effective intervention available to mitigate its burden. Advances in intensive care have increased survival to hospital discharge, but resolution of critical illness does not end a patient's struggles. New or worsening physical, cognitive, or mental health impairments may persist for years after an ICU stay and are collectively termed post-intensive care syndrome (PICS). These impairments are associated with rehospitalization, increased health care costs, reduced quality of life, and inability to return to work. Although physical rehabilitation, delirium prevention, and cognitive outcomes have received substantial attention, prevention of mental health morbidity remains largely unaddressed. More than one-third of critical illness survivors report symptoms of anxiety, depression, or post-traumatic stress disorder (PTSD) 6 to 12 months after discharge. Rates are even higher among survivors of acute respiratory failure, with up to two-thirds experiencing impairment in at least one psychiatric domain, often in all three, for years. No evidence-based intervention is available to prevent or effectively treat this morbidity. Most recognized risk factors, including female sex, alcohol misuse, unemployment, and premorbid psychopathology, are not modifiable. Among modifiable factors, frightening and delusional memories from the ICU appear to be especially important. Anxiety, depression, and PTSD can be conceptualized partly as disorders of memory content in which the emotional representation of a traumatic event persists beyond its adaptive purpose. Once established, these emotionally charged memories are difficult to treat. Psychological support may therefore need to begin early in critical illness, before traumatic memories become consolidated. Conventional psychological evaluation and treatment are difficult during an ICU stay, and little is known about psychological dysfunction in this setting. During critical illness, thinking may become literal and unusually sensitive to both direct and implied meanings. Patients may accept suggestions without critical appraisal and use communicated messages to interpret their circumstances. To address this heightened suggestibility, Dr. Varga and colleagues in Hungary adapted therapeutic suggestion to the ICU setting as psychological support based on positive suggestions (PSBPS). Therapeutic suggestion has been used for more than a century in anesthesia, surgery, palliative care, radiology, chronic pain, somatization disorders, obstetrics, and pediatrics. Critically ill patients may experience panic, loss of control, lack of privacy, painful procedures, and dependence on complex technology. They may perceive staff performing painful interventions as adversaries and may develop learned helplessness because they cannot control basic physiological needs. An effective ICU intervention should therefore include the patient as a valued member of the care team who can assist in recovery and participate in rehabilitation. Investigators developed specific suggestions that can be used verbatim with mechanically ventilated patients. PSBPS has been associated with earlier ventilator weaning and reduced sedative and analgesic requirements. Subsequent analyses suggested that early positive reframing was the most important component. This is consistent with research showing that fear conditioning may be altered during the initial memory-consolidation window. Mitigating information introduced after memory formation and recall, during the reconsolidation window, may also modify the emotional experience of the memory. Thus, early positive reframing may weaken or prevent traumatic emotional memories by shaping their consolidation and reconsolidation while memories remain labile. For critically ill patients, this approach requires psychological support as soon as feasible after admission and in parallel with medical care. PSBPS can be delivered regardless of a patient's level of participation and may begin during sedation. Semantic processing can continue during altered states of consciousness, and some patients later recall statements made while they were comatose. These preliminary findings support further evaluation of PSBPS as an early preventive intervention for psychological morbidity after critical illness. Methods: Design. This is a two-arm, single-center, prospective, randomized controlled trial comparing PSBPS with no PSBPS in critically ill adults. Trained ICU doulas will administer PSBPS to eligible patients. Eligible patients will be randomized at the earliest feasible time after meeting inclusion criteria. Randomization will be 1:1 to the intervention or non-intervention arm and stratified by ICU location. Both groups will receive standard medical care at the discretion of the ICU team. The intervention group will receive PSBPS as soon as feasible and daily thereafter. ICU doulas will also liaise with the patient's family, clinical team, and nursing staff. After ICU discharge and again at 6 months by telephone, participants in both groups will complete questionnaires assessing anxiety, depression, acute stress, and cognitive function. Questionnaire results will not be entered into the medical record. The intervention will occur once daily, and all participants assigned to PSBPS will receive the same intervention. Session duration will depend on the clinical situation. In prior experience, bedside sessions sometimes lasted more than 20 minutes, whereas procedures, tests, or other clinical needs occasionally required shorter sessions. Retention strategy. Questionnaire length and frequency have been minimized to reduce burden. Additional retention strategies include emphasizing the study's potential benefits, engaging participants as partners with the research team, and using the organized and persistent follow-up processes of the anesthesia clinical research unit. All available telephone numbers will be collected to facilitate follow-up. Participants will receive financial compensation after completing the 6-month questionnaires. Sample Size and Power A 2-point difference in the Hospital Anxiety and Depression Scale anxiety subscale (HADS-A) was considered clinically meaningful based on prior studies. In our preliminary study, the mean baseline HADS-A score after ICU discharge was 7.7 (SD 3.9). Assuming a pooled standard deviation of 4.0, 64 participants per arm would provide 80% power to detect a 2-point difference using a two-sided two-sample t-test with α=0.05. To account for anticipated attrition, enrollment was planned until 182 participants (91 per arm) had been randomized and completed the baseline post-ICU discharge HADS-A assessment. This sample size was expected to provide adequate power to evaluate the prespecified psychological and cognitive outcome measures assessed after ICU discharge and at 6-month follow-up, including symptoms of anxiety, depression, post-traumatic stress, cognitive function, and health-related quality of life. The study was also intended to provide data to inform the design of a future multicenter trial. Analysis Plan Demographic characteristics and in-hospital clinical characteristics abstracted from the electronic health record were summarized using descriptive statistics (means, medians, standard deviations, interquartile ranges, counts, and percentages, as appropriate). These variables were used to characterize the study population and, where appropriate, as covariates in adjusted analyses; they were not prespecified efficacy outcome measures. The effect of the intervention on the prespecified psychological and cognitive outcome measures was estimated using analysis of covariance (ANCOVA) with adjustment for relevant prerandomization characteristics identified in earlier studies. A nonparametric Wilcoxon rank-sum test was planned when appropriate. Interactions with relevant variables, including sex and race/ethnicity, were explored to assess whether intervention effects differed across key subgroups, although the study was not powered for these comparisons. Missing questionnaire data were anticipated primarily because of inability to complete assessments, death, or loss to follow-up. The primary analysis followed the intent-to-treat principle, with complete-case analyses supplemented by sensitivity analyses using multiple imputation and worst-case imputation where appropriate. Statistical significance was defined as a two-sided p\<0.05.

Interventions

OTHERPsychological Support Based on Positive Suggestions

Eligible patients will be randomized at the earliest possible time after meeting inclusion criteria. Patients will be randomized 1:1 to intervention by ICU doulas or a non-intervention arms stratified by ICU location. Both intervention and controls will receive standard medical care at the discretion of the ICU team. The intervention arm will receive PSBPS as soon as feasible and continue on a daily basis. Doulas will also liaise with family, the team, and with the nursing staff. Both intervention and standard of care arms will complete follow-up questionnaires measuring symptoms of anxiety, depression, acute stress and cognitive function after ICU discharge and at 6 months follow up by phone. All the patients randomized to the intervention arm will receive the same intervention.

Sponsors

Mayo Clinic
Lead SponsorOTHER
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

This will be a tho arm single-center, prospective, randomized, controlled trial comparing the effect of PSBPS vs. no PSBPS on psychological and clinical outcomes in the critically ill population. PSBPS will be administered by trained ICU doulas to eligible patients

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

\- Critically ill adult patients (age \>18) requiring non-invasive ventilation, high flow O2 or mechanical ventilation and expected to stay \>48 hours.

Exclusion criteria

* history of dementia * intellectual disability * suicide attempt * psychotic disorders such as schizophrenia * acute alcohol/substance intoxication or withdrawal * severe metabolic encephalopathy * patients on comfort care * Patients not expected to survive the hospital stay * Non-English speaking.

Design outcomes

Primary

MeasureTime frameDescription
Hospital Anxiety and Depression Scale - Anxietywithin 96 hours after ICU discharge and 6 months after hospital dischargeThis outcome will be evaluated using Hospital Anxiety and Depression Scale (HADS). The total scores range is 0-21 for both depression and anxiety scores. A higher score indicates a worse depression and anxiety. Comparison will be done between the score obtained from the control group and the intervention group within 96 hours after ICU discharge and at 6 months follow up

Secondary

MeasureTime frameDescription
Hospital Anxiety and Depression Scale-Depressionwithin 96 hours after ICU discharge and 6 months after hospital dischargeThis outcome will be evaluated using Hospital Anxiety and Depression Scale (HADS). The total scores range is 0-21 for both depression and anxiety scores. A higher score indicates a worse depression and anxiety. Comparison will be done between the score obtained from the control group and the intervention group within 96 hours after ICU discharge and at 6 months follow up

Countries

United States

Baseline characteristics

Characteristic
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
71 Participants
Age, Categorical
Between 18 and 65 years
70 Participants
Age, Continuous64.5 years
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
51 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
4 Participants
Region of Enrollment
United States
85 Participants
Sex: Female, Male
Female
32 Participants
Sex: Female, Male
Male
43 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
34 / 11426 / 160
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 1140 / 160

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 22, 2026